Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | GSK3A | P49840 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.36 |
| ▸ | CYP4F2 | P78329 | 4/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 4/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylene Chloride SCHEMBL3176439 | 0.96 | GAA (0.43) | GAAMGAMSIMGAM2ALDH1A1 | |
| Heptane SCHEMBL6925620 | 0.91 | NAAA (0.40) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL5864262 | 0.83 | GAA (0.43) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL10723443 | 0.81 | GAA (0.44) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL4288701 | 0.81 | GAA (0.44) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL181945 | 0.79 | GAA (0.52) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL8820595 | 0.77 | GAA (0.50) | GAAMGAMSIMGAM2ALDH1A1 | |
| Ethyl Acetate SCHEMBL7646921 | 0.76 | ALDH1A1 (0.52) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL4341048 | 0.76 | MEN1 (0.42) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL3967529 | 0.76 | MEN1 (0.41) | GAAMGAMSIMGAM2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 404 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116675636-A | Near-infrared two-photon dual-mode linkage response NTR & Cys fluorescent probe and preparation method and application thereof | 江苏辛巴生物医药有限公司 | 2023-09-01 | — | — | CN | claimed |
| US-8883167-B2 | Ethanol extract of Antrodia camphorata for inducing apoptosis and preparation method thereof | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2014-11-11 | — | — | US | claimed |
| US-20120141524-A1 | ETHANOL EXTRACT OF ANTRODIA CAMPHORATA FOR INDUCING APOPTOSIS AND PREPARATION METHOD THEREOF | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2012-06-07 | — | — | US | claimed |
| US-20100210869-A1 | ETHANOL EXTRACT OF ANTRODIA CAMPHORATA FOR INDUCING APOPTOSIS AND PREPARATION METHOD THEREOF | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2010-08-19 | — | — | US | claimed |
| CN-118221669-A | Derivatives as DNA polymerase Theta inhibitors | 艾立康药业股份有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-118063445-A | Pyrrolidine amide derivatives and use thereof | 广东东阳光药业股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-118063444-A | Azetidinamide derivatives and uses thereof | 广东东阳光药业股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| US-11969469-B2 | Pharmaceutical compositions having improved storage stability | ALKERMES PHARMA IRELAND LIMITED (IE) | 2024-04-30 | — | — | US | disclosed |
| US-20240131024-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING SORBITAN ESTERS | JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT | 2024-04-25 | — | — | US | disclosed |
| EP-4349832-A1 | CHEMICAL COUPLING LINKER AND USE THEREOF | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) | 2024-04-10 | — | — | EP | disclosed |
| US-20240109917-A1 | PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | ACTELION PHARMACEUTICALS LTD (CH) | 2024-04-04 | — | — | US | disclosed |
| US-11931355-B2 | Aripiprazole formulations having increased injection speeds | ALKERMES PHARMA IRELAND LIMITED (IE) | 2024-03-19 | — | — | US | disclosed |
| EP-0514193-A1 | N-linked imidazolyl-methyl benzofuran derivatives with antihypotensive activity | GLAXO GROUP LIMITED (GB) | 1992-11-19 | — | — | EP | disclosed |
| EP-0144729-B1 | 11-Substituted 5H,11H-pyrrolo[2,1-c][1,4]benzoxazepines, a process for their preparation and their use in medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1989-11-08 | — | — | EP | disclosed |
| US-4855307-A | Acetic acid ester of haloperidol | H. LUNDBECK A/S (DK) | 1989-08-08 | — | — | US | disclosed |
| US-4681879-A | 11-substituted 5H,11H-pyrrolo[2,1-c][1,4]benzoxazepines as antipsychotic and analgesic agents | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1987-07-21 | — | — | US | disclosed |
| EP-0204317-A2 | 2-Thio or oxo-4-aryl or heterocyclo-1,5(2H)-pyrimidinedicarboxylic acid diesters and 3-acyl-5-pyrimidinecarboxylic acids and esters | E.R. Squibb & Sons, Inc. (US) | 1986-12-10 | — | — | EP | disclosed |
| US-4608374-A | 11-substituted 5H,11H-pyrrolo[2,1-c][1,4]benzoxazepines as antipsychotic and analgesic agents | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1986-08-26 | — | — | US | disclosed |
| EP-0144729-A1 | 11-Substituted 5H,11H-pyrrolo[2,1-c][1,4]benzoxazepines, a process for their preparation and their use in medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1985-06-19 | — | — | EP | disclosed |
| US-4061655-A | ANTIINFLAMMATORY | E. R. SQUIBB & SONS, INC. (US) | 1977-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11931355-B2 | Aripiprazole formulations having increased injection speeds | CYP2C19, ATP6V1B2, CYP2D6 | GAA 2185/4885MGAM 2148/4885SI 798/4885 |
| US-11969469-B2 | Pharmaceutical compositions having improved storage stability | TREH, CTSA, MAOA | GAA 14/4885MGAM 312/4885SI 421/4885 |
| US-20240131024-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING SORBITAN ESTERS | SORBS1, ABCG2, FABP7 | GAA 111/4885MGAM 984/4885SI 292/4885 |
| US-20120141524-A1 | ETHANOL EXTRACT OF ANTRODIA CAMPHORATA FOR INDUCING APOPTOSIS AND PREPARATION METHOD THEREOF | BAX, API5, BCL2 | GAA 1854/4885MGAM 3379/4885SI 118/4885 |
| US-20100210869-A1 | ETHANOL EXTRACT OF ANTRODIA CAMPHORATA FOR INDUCING APOPTOSIS AND PREPARATION METHOD THEREOF | BAX, API5, BCL2 | GAA 1854/4885MGAM 3379/4885SI 118/4885 |
| US-20240109917-A1 | PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS | PDGFRA, PDGFRB, ABL1 | GAA 1529/4885MGAM 4424/4885SI 4063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.